CA1336821C - Nucleosides pour usage therapeutique - Google Patents
Nucleosides pour usage therapeutiqueInfo
- Publication number
- CA1336821C CA1336821C CA000616870A CA616870A CA1336821C CA 1336821 C CA1336821 C CA 1336821C CA 000616870 A CA000616870 A CA 000616870A CA 616870 A CA616870 A CA 616870A CA 1336821 C CA1336821 C CA 1336821C
- Authority
- CA
- Canada
- Prior art keywords
- formulation according
- uracil
- unit dosage
- fluoro
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878726136A GB8726136D0 (en) | 1987-11-07 | 1987-11-07 | Therapeutic nucleosides |
GB8726136 | 1987-11-07 | ||
CA000582322A CA1333391C (fr) | 1987-11-07 | 1988-11-04 | Nucleosides therapeutiques |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000582322A Division CA1333391C (fr) | 1987-11-07 | 1988-11-04 | Nucleosides therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1336821C true CA1336821C (fr) | 1995-08-29 |
Family
ID=25672223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000616870A Expired - Fee Related CA1336821C (fr) | 1987-11-07 | 1994-05-31 | Nucleosides pour usage therapeutique |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1336821C (fr) |
-
1994
- 1994-05-31 CA CA000616870A patent/CA1336821C/fr not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU668860B2 (en) | Antiviral nucleoside combination | |
EP0206497B1 (fr) | Nucléosides thérapeutiques et leur préparation | |
IE56503B1 (en) | Antiviral nucleosides | |
US5071983A (en) | Therapeutic nucleosides | |
EP0317128B1 (fr) | Pyrimidine Nucléosides Anti-HIV | |
US5157114A (en) | 2',3'-dideoxy-3'-fluoro-5-ethyngluridine | |
US4920210A (en) | 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside | |
EP0625158B1 (fr) | Nucleosides therapeutiques de la serie 2',3'-dideoxy-3'-fluoro-purine | |
CA1336821C (fr) | Nucleosides pour usage therapeutique | |
EP0306597A2 (fr) | Nucléosides antiviraux | |
US5198539A (en) | 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine | |
WO1988009332A1 (fr) | Nucleosides a usage therapeutique | |
EP0366287A1 (fr) | Nucléosides thérapeutiques | |
CA1327005C (fr) | Nucleosides therapeutiques | |
EP0294113A1 (fr) | Nucléosides thérapeutiques | |
CA1340519C (fr) | Nucleosides antiviraux | |
NZ224007A (en) | 3'-azido-3'-deoxythymidine derivatives as antiviral agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |